Evidence map›Paper›PMID 34905456›Full record

ArticleAfrican journal of AIDS research : AJAR2021

iPrevent: Engaging youth as long-acting HIV prevention product co-researchers in Cape Town, South Africa.

Miriam Hartmann, Alexandra M Minnis, Emily Krogstad, Sheily Ndwayana, Siyaxolisa Sindelo, Millicent Atujuna, Shannon O'Rourke, Linda-Gail Bekker, Elizabeth T Montgomery

Open access · greenAbstract read
In one paragraph

Article in African journal of AIDS research : AJAR, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Miriam HartmannWomen's Global Health Imperative, Research Triangle Initiative (RTI) International, San Francisco, USA.ORCID 0000-0001-8109-9679
Alexandra M MinnisWomen's Global Health Imperative, Research Triangle Initiative (RTI) International, San Francisco, USA.ORCID 0000-0002-2943-2005
Emily KrogstadWomen's Global Health Imperative, Research Triangle Initiative (RTI) International, San Francisco, USA.ORCID 0000-0003-2736-8350
Sheily NdwayanaThe Desmond Tutu HIV Centre, University of Cape Town, South Africa.
Siyaxolisa SindeloThe Desmond Tutu HIV Centre, University of Cape Town, South Africa.ORCID 0000-0003-0870-9850
Millicent AtujunaThe Desmond Tutu HIV Centre, University of Cape Town, South Africa.ORCID 0000-0003-1287-2634
Shannon O'RourkeWomen's Global Health Imperative, Research Triangle Initiative (RTI) International, San Francisco, USA.ORCID 0000-0002-0691-3308
Linda-Gail BekkerThe Desmond Tutu HIV Centre, University of Cape Town, South Africa.ORCID 0000-0002-0755-4386
Elizabeth T MontgomeryWomen's Global Health Imperative, Research Triangle Initiative (RTI) International, San Francisco, USA.ORCID 0000-0002-5477-4445
Desmond Tutu HIV Foundation · ZARTI International · US

Funding

End-user research to optimize adherence to injectable HIV prevention approachesR01MH105262 · NIMH · RESEARCH TRIANGLE INSTITUTE · PI MONTGOMERY, ELIZABETH TRASK · 2015 to 2017
$1.8M
NIMH NIH HHS R01 MH105262
6 · The paper itself

Abstract

South African youth are one of the highest risk groups, globally, for HIV acquisition. Identifying prevention methods that will be acceptable and used consistently is an urgent priority. Engaging youth as co-designers is a targeted strategy to achieve the goal of developing prevention products that meet youth's needs. The iPrevent study engaged male and female youth, aged 18-24 years, in Cape Town, South Africa, to co-design critical aspects of the research project aimed at understanding youth preferences for long-acting pre-exposure prophylaxis (PrEP). An established advisory board of young men who have sex with men, women who have sex with men and men-who-have-sex-with-men, as well as a purposively selected youth cohort were involved in film-making, survey design and interpretation of study results. Convening youth as co-designers had several impacts on iPrevent's approach and outputs. Youth input informed the use of local actors in the study's educational video, creating a "real-world" community setting that meaningfully situated the content. Their participation led to the successful development of survey language and images to explain scientific concepts in terms that would resonate (e.g. chili peppers to express product-associated pain). Lastly, their insight reviewing results led to clarifications around misinterpretations of risk perception and confirmed youth's desires for products that fit into their goals around family, future happiness and education. The engagement of youth through creative, interactive activities contributed to adaptations of the study design, research implementation and understanding of results. This was important for connecting with young end-users and translating study findings for product developers in a way that reflected the context of their lives.

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisSexual and Gender MinoritiesAdolescentFemaleHomosexuality, MaleHumansMaleSouth AfricaAnti-HIV Agentspre-exposure prophylaxissub-Saharan Africayouth engagement

Identifiers

PMID34905456
PMCPMC12967857
OpenAlexW4200300253

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.